Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Creatine transporter deficiency impairs stress adaptation and brain energetics homeostasis
Hong-Ru Chen, Xiaohui Zhang-Brotzge, Yury M. Morozov, Yuancheng Li, Siming Wang, Helen Heju Zhang, Irena S. Kuan, Elizabeth M. Fugate, Hui Mao, Yu-Yo Sun, Pasko Rakic, Diana M. Lindquist, Ton DeGrauw, Chia-Yi Kuan
Hong-Ru Chen, Xiaohui Zhang-Brotzge, Yury M. Morozov, Yuancheng Li, Siming Wang, Helen Heju Zhang, Irena S. Kuan, Elizabeth M. Fugate, Hui Mao, Yu-Yo Sun, Pasko Rakic, Diana M. Lindquist, Ton DeGrauw, Chia-Yi Kuan
View: Text | PDF
Research Article Metabolism Neuroscience

Creatine transporter deficiency impairs stress adaptation and brain energetics homeostasis

  • Text
  • PDF
Abstract

The creatine transporter (CrT) maintains brain creatine (Cr) levels, but the effects of its deficiency on energetics adaptation under stress remain unclear. There are also no effective treatments for CrT deficiency, the second most common cause of X-linked intellectual disabilities. Herein, we examined the consequences of CrT deficiency in brain energetics and stress-adaptation responses plus the effects of intranasal Cr supplementation. We found that CrT-deficient (CrT–/y) mice harbored dendritic spine and synaptic dysgenesis. Nurtured newborn CrT–/y mice maintained baseline brain ATP levels, with a trend toward signaling imbalance between the p-AMPK/autophagy and mTOR pathways. Starvation elevated the signaling imbalance and reduced brain ATP levels in P3 CrT–/y mice. Similarly, CrT–/y neurons and P10 CrT–/y mice showed an imbalance between autophagy and mTOR signaling pathways and greater susceptibility to cerebral hypoxia-ischemia and ischemic insults. Notably, intranasal administration of Cr after cerebral ischemia increased the brain Cr/N-acetylaspartate ratio, partially averted the signaling imbalance, and reduced infarct size more potently than intraperitoneal Cr injection. These findings suggest important functions for CrT and Cr in preserving the homeostasis of brain energetics in stress conditions. Moreover, intranasal Cr supplementation may be an effective treatment for congenital CrT deficiency and acute brain injury.

Authors

Hong-Ru Chen, Xiaohui Zhang-Brotzge, Yury M. Morozov, Yuancheng Li, Siming Wang, Helen Heju Zhang, Irena S. Kuan, Elizabeth M. Fugate, Hui Mao, Yu-Yo Sun, Pasko Rakic, Diana M. Lindquist, Ton DeGrauw, Chia-Yi Kuan

×

Figure 6

CrT deficiency causes greater infarct and ATP depletion after cerebral ischemia.

Options: View larger image (or click on image) Download as PowerPoint
CrT deficiency causes greater infarct and ATP depletion after cerebral i...
(A) LC-MS quantification of the brain ATP, Cr, and PCr levels in contralateral (Con) and ipsilateral (Ipsi) hemispheres in CrT+/y versus CrT–/y mice 24 hours after photoactivation (n = 4 for each). (B and C) Immunoblotting and quantification of the p-AMPK/autophagy and mTOR signaling pathway activity in P16 CrT+/y versus CrT–/y mice 24 hours after photoactivation directed at the proximal branch of the middle cerebral artery. The protein expression levels in the contralateral hemisphere of CrT+/y mice were used as the baseline. (D and E) Representative brain sections and quantification of the infarct size in untreated CrT+/y (n = 10) and CrT–/y mice (n = 14), intranasal 184 mg/kg Cr–treated CrT+/y (n = 12) and CrT–/y mice (n = 11), and intraperitoneal 200 mg/kg Cr–treated CrT+/y (n = 7) and CrT–/y mice at 16 days of age (n = 9). The intranasal and intraperitoneal Cr treatment was administered within 30 minutes after photoactivation. The violin plots in C are representative of 3 independent experiments, with n = 3 biological replicates; all other data are shown as mean ± SEM. All statistical analyses were performed using 2-way ANOVA followed by Tukey’s multiple comparison post hoc test. IN, intranasal; IP, intraperitoneal.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts